1. Home
  2. UHAL vs RGEN Comparison

UHAL vs RGEN Comparison

Compare UHAL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U-Haul Holding Company

UHAL

U-Haul Holding Company

HOLD

Current Price

$53.04

Market Cap

9.9B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.66

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UHAL
RGEN
Founded
1945
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UHAL
RGEN
Price
$53.04
$166.66
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$170.90
AVG Volume (30 Days)
181.1K
813.6K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.19
0.03
Revenue
$5,972,459,000.00
$707,890,000.00
Revenue This Year
$3.18
$17.50
Revenue Next Year
$3.71
$12.74
P/E Ratio
$44.35
$6,528.73
Revenue Growth
5.86
11.74
52 Week Low
$48.48
$102.97
52 Week High
$75.19
$182.52

Technical Indicators

Market Signals
Indicator
UHAL
RGEN
Relative Strength Index (RSI) 53.21 61.26
Support Level $48.48 $146.56
Resistance Level $53.14 $174.01
Average True Range (ATR) 1.24 6.82
MACD 0.40 1.44
Stochastic Oscillator 86.99 74.38

Price Performance

Historical Comparison
UHAL
RGEN

About UHAL U-Haul Holding Company

U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: